GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.

All News Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Equities

874 CNE100000387

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-05-14 am EDT			5-day change	1st Jan Change
23.05 ^HKD	+0.22%		+6.47%	+5.98%

Apr. 26	Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 15	Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Baiyunshan Pharmaceutical's 2023 Profit Rises 2%	Mar. 18	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Ordinary Dividend for the Year Ended 31 December 2023	Mar. 15	CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug	Mar. 01	MT
Guangzhou Pharma Unit Gets Green Light to Trial Oral Liquid Drug	Feb. 09	MT
Guangzhou Baiyunshan Pharmaceutical Arm Floats 1 Billion Yuan Biomedical VC Fund	Dec. 19	MT
Guangzhou Baiyunshan Pharmaceutical Ends Spin-Off Plans, Seeks China Listing for Subsidiary	Dec. 19	MT
Guangzhou Pharma Expands Scope of Drug Production License	Nov. 13	MT
Guangzhou Baiyunshan Pharmaceutical's Profit Up 11% in Q3	23-10-30	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Baiyunshan Pharmaceutical Reports Increase in H1 Attributable Profit	23-09-13	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Ex-dividend day for final dividend	23-06-13	FA
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to Shanghai Stock Exchange 180 Value Index	23-06-12	CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to SSE 180 Index	23-06-12	CI
Guangzhou Pharma Registers Pain-Relief, Anti-Inflammatory Drugs in Russia	23-05-26	MT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2023	23-04-27	CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Election of the Supervisor Representing the Employees of the 9th Session of the Supervisory Committee	23-04-25	CI
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Dividend for the Year Ended 31 December 2022	23-03-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Equities

874

CNE100000387

All News

Filters